William Wood
Stock Analyst at B. Riley Securities
(3.78)
# 2,031
Out of 4,491 analysts
50
Total ratings
58.1%
Success rate
12.4%
Average return
Main Sectors:
Stocks Rated by William Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics | Reiterated: Buy | $85 | $39.43 | +115.60% | 1 | Jun 25, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $7 | $1.99 | +252.64% | 2 | Jun 2, 2026 | |
| EQ Equillium | Reiterated: Buy | $6 | $2.94 | +104.08% | 2 | Jun 2, 2026 | |
| IMUX Immunic | Maintained: Buy | $50 → $27 | $14.50 | +86.21% | 10 | May 22, 2026 | |
| AARD Aardvark Therapeutics | Maintained: Buy | $8 → $7 | $5.32 | +31.58% | 3 | May 15, 2026 | |
| ALT Altimmune | Maintained: Buy | $13 | $3.11 | +318.01% | 1 | Mar 6, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintained: Buy | $560 → $670 | $546.51 | +22.60% | 3 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiated Coverage: Buy | $5 | $1.67 | +199.40% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Maintained: Buy | $3 | $1.02 | +195.57% | 1 | Nov 21, 2025 | |
| VERU Veru Inc. | Reiterated: Buy | $50 | $2.68 | n/a | 7 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $4.60 | n/a | 10 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $17.04 | n/a | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $4.43 | n/a | 4 | May 2, 2024 |
Viking Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $85
Current: $39.43
Upside: +115.60%
Palisade Bio
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $1.99
Upside: +252.64%
Equillium
Jun 2, 2026
Reiterated: Buy
Price Target: $6
Current: $2.94
Upside: +104.08%
Immunic
May 22, 2026
Maintained: Buy
Price Target: $50 → $27
Current: $14.50
Upside: +86.21%
Aardvark Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $5.32
Upside: +31.58%
Altimmune
Mar 6, 2026
Maintained: Buy
Price Target: $13
Current: $3.11
Upside: +318.01%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintained: Buy
Price Target: $560 → $670
Current: $546.51
Upside: +22.60%
OKYO Pharma
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.67
Upside: +199.40%
Cognition Therapeutics
Nov 21, 2025
Maintained: Buy
Price Target: $3
Current: $1.02
Upside: +195.57%
Veru Inc.
Feb 11, 2025
Reiterated: Buy
Price Target: $50
Current: $2.68
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $12 → $11
Current: $4.60
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $10
Current: $17.04
Upside: n/a
May 2, 2024
Maintained: Buy
Price Target: $4
Current: $4.43
Upside: n/a